2.880USD+1.05%Mkt Cap: 975.39M $P/E: 48.001d ago
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price…
Industry Peers
Health Information Servicesvs Health Information Services
P/E
Pricier
P/B
Avg
1M Perf
Avg
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
—
—
Indicators:|
Key Statistics
Company
Market Cap975.39M $
Enterprise Value1.28B $
Revenue (TTM)787.89M $
Gross Profit739.26M $
Net Income (TTM)30.44M $
Revenue/Share2.273 USD
Last Price2.880 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees697
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)48.00
P/E (Forward)8.04
PEG—
EV/EBITDA11.71
EV/Revenue1.63
P/S1.24
P/B1.56
EPS (TTM)0.06
EPS (Forward)0.36
52W Range
1.77027% of range5.810
52W High5.810 USD
52W Low1.770 USD
Profitability
Gross Margin92.77%
Oper. Margin7.22%
EBITDA Margin13.89%
Profit Margin3.82%
ROE4.94%
ROA2.17%
Growth
Revenue Growth-4.40%
Earnings Growth-88.30%
Cash Flow & Leverage
Operating CF167.90M $
CapEx (TTM)74.02M $
FCF Margin10.74%
FCF Yield8.68%
Net Debt305.64M $
Net Debt/EBITDA2.79
Balance Sheet
Debt/Equity0.88
Current Ratio1.47
Quick Ratio0.56
Book Value/Sh1.843 USD
Cash/Share0.6960 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.181 USD
Upside (mean)+10.4%
Target Range2.250 USD – 4.000 USD
$2.250+10.4% to mean$4.000
# Analysts13
Ownership
Shares Out.104.71M
Float91.53M
Insiders12.86%
Institutions56.62%
Short Interest
Short Ratio4.8d
Short % Float8.02%
Short % Out.2.21%
Shares Short7.49M
Short (prev mo.)10.89M
Technical
SMA 502.620 (+9.9%)
SMA 2002.828 (+1.8%)
Beta1.61
S&P 52W Chg20.05%
Avg Vol (30d)1.30M
Avg Vol (10d)1.24M
Technical Indicators
RSI (14)59.3
MACD0.0423
MACD Signal0.0295
MACD Hist.+0.0128
BB Upper2.938 USD
BB Middle2.717 USD
BB Lower2.496 USD
BB Width16.24%
ATR (14)0.1355 USD
Vol Ratio (20d)0.79x